Aug 2026· Journal of Pathology· Vol 270, pp. 380 - 395· 0 citations· 74 references
Medicine
TL;DR
It is proposed that MEK inhibitors may represent a relevant therapeutic option for BRAF fusions and non‐V600 BRAF mutant tumours, providing a novel strategy for this challenging disease.
Early‐onset colorectal cancer (EOCRC) is increasing worldwide, yet the molecular basis underlying its age‐related heterogeneity remains insufficiently defined. To address this gap, we performed whole‐exome sequencing in a Chinese EOCRC cohort diagnosed before 40 years of age (
n
= 111), bulk transcriptome sequen...
Yang Guo, Ya-Jiao He, Tao Zhou et al.· MedComm - Oncology· 0 citations
This review provides a comprehensive overview of SGC entities and summarizes current knowledge of their mutational landscapes to improve understanding of their biology and identify potential therapeutic targets, particularly for aggressive tumors lacking treatment options in advanced stages.
Lara Racz, A. Böer-Auer, F. Meier et al.· European Journal of Cancer· 0 citations
Genomic or transcriptomic sequencing guides the precision of cervical cancer (CC) diagnosis; however, the molecular profile of Asian patients remains poorly understood. We established a comprehensive multi-omics cohort comprising 112 tumor-normal adjacent tissue pairs from Chinese CC patients. Our integrated analysis r...
Tao Pan, Xu-Cui Zhuang, Ya Zhang et al.· PLoS Biology· 0 citations
Across 236 whole-genome sequencing osteosarcoma samples, five genomic hotspots of clustered structural variation collectively altered in 58% of tumors were uncovered, and localized transcriptional dysregulation at hotspot event loci was found, linking these structural alterations to a less differentiated cell state.
Shreya Raman, Thorsten Kaltenbacher, David Merrell et al.· bioRxiv· 0 citations
Abstract Background Colorectal cancer (CRC) is a biologically diverse malignancy driven by a complex interplay of genetic mutations, epigenetic changes, tumour microenvironmental factors and host–microbial interactions. Foundational molecular events including APC-associated Wnt/β-catenin dysregulation, TP53 inactivatio...
Suvarna Bhokare, A. Wagh, P. Jadhav et al.· Biomarkers· 0 citations
The distinct association of KRAS and KIT with the seminomatous lineage, alongside the broad histological distribution of PTMA, provides novel insights into tumor biology, and may contribute to improved diagnostic precision and the development of tailored therapeutic interventions for patients with TGCT.
B. Calim-Gurbuz· Trends in Surgical Sciences· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.